PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 1, 2026International Journal of Molecular Sciences0 citationsOpen Access

Mini-Galaxy: Rethinking Complex Human Diseases Through the Lens of Systems Biology and Multilayered AI Network Perspectives

View Full Paper
CCCristina Belo CorreiaCUChoong Yong UngZZZ Zhang

Key Points

  • This study aims to establish a new framework for understanding complex human diseases through systems biology and AI.
  • Proposing the Mini-Galaxy Model (MGM) to represent cells as multilayered biological networks.
  • Delineating strategies for constructing and comparing MGMs across different health conditions.
  • Operationalizing the MGM as a platform for translational medicine to prioritize and edit disease targets.
  • Identifying the emergent behaviors of genes as key drivers of disease beyond traditional measurements.
  • Providing actionable insights for biomarker discovery and target selection for interventions.
  • Facilitating a streamlined approach for drug repurposing.

Abstract

Human diseases are complex and arise from the coordinated action of multiple genes and their protein products. Genes’ behaviors extend beyond genetic variants, mutations, and differential expressions. Their coordinated activity across biological scales (molecules, cells, tissues, organs) produces emergent behaviors that shape health and disease. These emergent behaviors span time and space and are often hard to measure directly from observation when using standard experimental measurements. Yet these “hidden” or latent gene characteristics can be powerful drivers of disease. We propose a Mini-Galaxy Model (MGM), a systems-level AI-driven network framework that models cells as “mini-galaxies” composed of multilayered biological information, with each layer encoding a different dimension of genes’ behavior. Here, we delineate a strategy on how to construct and compare MGMs across health and disease and map their etiological relatedness. We also operationalize the MGM as a discovery platform for translational medicine, offering modules to allow target prioritization and editing. By reframing human diseases as the result of emergent behavior of multilayered multimode biological networks and their perturbations, the MGM yields actionable rules to streamline biomarker discovery, guide target selection and enable rational design of combinatorial interventions, and accelerate drug repurposing.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Correia et al. (2026) studied this question.

synapsesocial.com/papers/69cd7a3e5652765b073a7447https://doi.org/10.3390/ijms27073161
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1edgeR : a Bioconductor package for differential expression analysis of digital gene expression data2009 · 45,250 citations
  2. 2The language of covalent histone modifications2000 · 8,665 citations
  3. 3The statistical properties of gene-set analysis2016 · 326 citations
  4. 4A brave new world of RNA-binding proteins2018 · 1,938 citations
  5. 5Mutational Heterogeneity in Human Cancers: Origin and Consequences2009 · 249 citations